Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions

March 23, 2026 updated by: Marleen Kunneman, Leiden University Medical Center

The goal of this clinical study is to assess differences in collaborative efforts to make care fit between clinical encounters in usual care and those using the Making Care Fit tool among young adults with type 1 diabetes and their clinicians.

The main question it aims to answer is:

What are the differences in collaborative efforts to make care fit between clinical encounters in usual care and those using the Making Care Fit tool?

Researchers will compare clinical encounters in usual care with encounters supported by the Making Care Fit tool to examine differences in collaborative efforts to align care and daily life.

Participants will:

  • Take part in an observed clinical encounter with their clinician
  • Participate in a post-encounter video-stimulated interview reflecting on the consultation
  • Complete questionnaires about their experiences of the consultation

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Young adults (age 18-30)
  • with ≥1 year since the diagnosis of type 1 diabetes
  • receiving ongoing treatment at participating diabetes clinics (Leiden university medical center (LUMC), Diabeter),
  • able to speak and read Dutch
  • able to provide informed consent for study participation

Exclusion Criteria:

  • People who do not fit the participant requirements
  • People who cannot give consent themselves (who are incapacitated)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Care as usual
Participants receive standard diabetes care at their clinic. Clinical encounters are observed and assessed to compare collaborative efforts with those in the Making Care Fit Tool arm.
Experimental: Make Care Fit tool
A web-based tool designed to help young adults with type 1 diabetes prepare for care plan design during their clinical encounter by structuring and prioritizing their experiences and efforts in making care fit.
Other Names:
  • MCF tool

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Observable efforts of collaboration to align care and life, with and without using the tool.
Time Frame: 1 month from enrollment to the consultation
Qualitative coding of observations
1 month from enrollment to the consultation
Perceived and unobservable efforts to align care and life.
Time Frame: 2 months from enrollment into the study to the video stimulated interview
Qualitative coding
2 months from enrollment into the study to the video stimulated interview
Perceived alignment of care plan and life.
Time Frame: 4 months from enrollment to filling out the last questionnaire
Young adults & clinicians: Open-ended question: "why does your care plan make sense?"
4 months from enrollment to filling out the last questionnaire

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variety and quality of themes discussed
Time Frame: 1 month from enrollment to consultation
Quantitative coding of observations, self-developed
1 month from enrollment to consultation
Collaborative care plan design
Time Frame: 1 month from enrollment to consultation
SDMo (reported on 1-10 scale) with higher scores suggesting more collaborative behaviours
1 month from enrollment to consultation
Fidelity of the use of the Making Care Fit tool
Time Frame: 1 month from enrollment to the consultation
Quantitative coding of observations, self-developed
1 month from enrollment to the consultation
Unhurried conversations
Time Frame: 1 month from enrollment to consultation
Unhurried Collaboration Assessment Tool (UCAT), 37 items to be scored on a 1-5 scale.
1 month from enrollment to consultation
Perceived treatment burden, and acceptability of this burden.
Time Frame: 4 months from enrollment to filling out the last questionnaire
Young adults: Treatment Burden Questionnaire (TBQ), 15 items to be scored on a 0-10 scale; 1 item on acceptability of burden.
4 months from enrollment to filling out the last questionnaire
Perceived diabetes distress
Time Frame: 4 months from enrollment to filling out the last questionnaire
Young adults: Diabetes distress scale (DDS) screening instrument, 2 items to be scored on a 1-6 scale.
4 months from enrollment to filling out the last questionnaire
Self-reported fidelity of using the Making Care Fit tool outside of the clinical encounter
Time Frame: 1 month from enrollment to concluding the consultation
Young adults & clinicians: 3 items about fidelity and and acceptability
1 month from enrollment to concluding the consultation
Perceived clinical empathy
Time Frame: 1 month from enrollment to after the consultation
Young adults: Consultation And Relational Empathy (CARE) measure, 10 items to be scored on a 1-5 scale.
1 month from enrollment to after the consultation
Written information by patient in making care fit tool
Time Frame: 1 month from enrollment to having the consultation
Qualitative coding
1 month from enrollment to having the consultation
patient involvement
Time Frame: 1 month after enrollment during the clinical consultation
OPTION12 (reported on 0-100 scale) with a higher score being more patient involvement
1 month after enrollment during the clinical consultation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Consultation characteristics
Time Frame: 1 month from enrollment to consultation
Encounter duration, diabetes clinic, consultation type (in-person or digital)
1 month from enrollment to consultation
Diabetes-specific characteristics
Time Frame: 4 months from enrollment to last questionnaire filled out
8 items (self-developed): Treatment regime, year of diagnosis, events of ketoacidosis and hypoglycaemia, HbA1c.
4 months from enrollment to last questionnaire filled out
Consultation characteristic
Time Frame: 4 months from enrollment to last questionnaire
1 item (self-developed: Duration of patient/clinician relationship in years
4 months from enrollment to last questionnaire
Work-related characteristics
Time Frame: 1 month from enrollment to consultation
2 items (self-developed): Clinicians' years worked, clinical background
1 month from enrollment to consultation
Participant characteristics
Time Frame: 4 months from enrollment to last questionnaire

Young adults: 7 items (self-developed): Age, gender, household situation, socioeconomic status, comorbidity, level of education13

Clinicians: 2 items (self-developed):

Age, gender.

4 months from enrollment to last questionnaire

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 13, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

March 17, 2026

First Submitted That Met QC Criteria

March 23, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

As this is a qualitative study data from participants might be easy traced back to the individuals.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes

Clinical Trials on Care as usual

Subscribe